Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-030412
Filing Date
2023-11-06
Accepted
2023-11-06 17:01:09
Documents
65
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tgtx20230930_10q.htm   iXBRL 10-Q 1512634
2 EXHIBIT 31.1 ex_578363.htm EX-31.1 12342
3 EXHIBIT 31.2 ex_578364.htm EX-31.2 12686
4 EXHIBIT 32.1 ex_578365.htm EX-32.1 5756
5 EXHIBIT 32.2 ex_578366.htm EX-32.2 6073
  Complete submission text file 0001437749-23-030412.txt   5974652

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA tgtx-20230930.xsd EX-101.SCH 55039
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tgtx-20230930_cal.xml EX-101.CAL 41906
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tgtx-20230930_def.xml EX-101.DEF 378867
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE tgtx-20230930_lab.xml EX-101.LAB 326894
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tgtx-20230930_pre.xml EX-101.PRE 401179
59 EXTRACTED XBRL INSTANCE DOCUMENT tgtx20230930_10q_htm.xml XML 700553
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

EIN.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32639 | Film No.: 231380660
SIC: 2834 Pharmaceutical Preparations